CHI's Structure-Based Drug Design

Register Today! 

Topics include:

PLUS

Pre-Conference Workshop: Wednesday, June 3

Designing Kinase Inhibitors

Hear from thought leaders including:

Structure and Function of the G-Protein Coupled Receptor Family

Raymond C. Stevens, Ph.D., Professor, Departments of Molecular Biology and Chemistry, Scripps Research Institute

Structure-Based and Ligand-Based Computational Modeling of Pharmacological Profiles

Ajay N. Jain, Ph.D., Professor, Cancer Research Institute & Department of Lab Medicine, University of California San Francisco

Discovery of Novel Cyclin-Dependent Kinase Inhibitors: A CDK2 Case Study in Structure-Based Drug Design

José Duca, Ph.D., Senior Principal Scientist, 3D-Drug Design Department, Schering Plough Research Institute

The Race for Chemical and Biological Space: A Drug Design Perspective

Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design

Predicting the Activity of Congeneric Series

W. Patrick Walters, Ph.D., Senior Research Fellow, Computational Chemistry and Molecular Modeling, Vertex Pharmaceuticals, Inc.

Towards Rational Drug Design for Intrinsically Unstructured Proteins - Small Molecules Mediated Inhibition of a-Synuclein Aggregation

Gergely Toth, Ph.D., Scientist, Computational Chemistry and Biology, Chemistry, Elan Pharmaceuticals

For questions or suggestions about the meeting, please contact:
Micah Lieberman, Conference Producer
Phone:  541-482-4709
E-mail: mlieberman@pharmaseries.com 

For media partnership opportunities, please contact:
James Prudhomme, Marketing Manager
Phone: 781-972-5486
E-mail: jprudhomme@healthtech.com

For exhibit, partnering and sponsorship information, please contact:
Katelin Fitzgerald, Manager Business Development
Phone: 781-972-5458
Email: kfitzgerald@healthtech.com